Medications - Page 82

November 14, 2016

Blood pressure, cholesterol drugs fail to slow cognitive decline: study

Taking medicines to lower blood pressure and cholesterol failed to prevent cognitive and functional declines in older adults with moderate risk of heart disease, according to results of a clinical trial presented on Sunday.

November 14, 2016

Drugmakers improve access for poor, GSK ranked top

The world's top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of products affordable, according to a report on Monday.

November 14, 2016

Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen: study

Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to cause heart problems that spurred the withdrawal of rival Vioxx, according to a large 10-year study presented on Sunday.

November 9, 2016

Internal watchdog told Medicare, Medicaid centers EpiPen was misclassified in 2009

The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV's EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said Tuesday.

November 3, 2016

FDA highlights liver safety issues in Cempra drug review

Cempra Inc's experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration.

November 2, 2016

Brexit threatens supply of new drugs, report warns

British patients could end up not being able to access modern medicines if there is a "hard Brexit", a think tank report endorsed by a former Conservative health minister warned on Wednesday.

November 1, 2016

Beautiful 'freak' snake may ease your pain one day

Ibuprofen for your splitting headache, or venom from the "killer of killers"?

November 1, 2016

Novartis breast cancer drug gets FDA fast track, takes on Pfizer

The U.S. Food and Drug Administration gave fast-track review status to Novartis's medication ribociclib in first-line treatment of postmenopausal women with advanced breast cancer as the Swiss company seeks to challenge Pfizer's Ibrance drug.

November 1, 2016

What you need to know about Auvi-Q, the new EpiPen alternative

Here's some welcome news for anyone with severe allergies longing for another option besides the famously overpriced EpiPen: Auvi-Q is coming back on the market in the United States in the first half of 2017, according to its maker, Kaléo.

October 31, 2016

Drugmakers turn cheap generics into expensive pills

Kendall Jack was dismayed when her health plan stopped covering her migraine drug Treximet earlier this year.